LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
NCT04699773
This study is recruiting at 5 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to evaluate the treatment regimen of using Laser Interstitial Thermal Therapy (LITT) and Hypo-fractionated Radiation Therapy to treat patients with newly diagnosed gliomas.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Glioma
- Glioblastoma
- Brain Tumor
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- University of Maryland, Baltimore
- Last updated on ClinicalTrials.gov
- May 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 5
- Maryland Proton Treatment Center · Baltimore, MD
- University of Maryland Greenebaum Cancer Center · Baltimore, MD
- UCH Kaufman Cancer Center · Bel Air, MD
- Central Maryland Radiation Oncology · Columbia, MD
- Baltimore Washington Medical Center · Glen Burnie, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.